(WKL) Wolters Kluwer - Overview
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0000395903
Stock:
Total Rating 39
Risk 69
Buy Signal 0.21
| Risk 5d forecast | |
|---|---|
| Volatility | 35.9% |
| Relative Tail Risk | -6.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.46 |
| Alpha | -65.23 |
| Character TTM | |
|---|---|
| Beta | 0.445 |
| Beta Downside | -0.057 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.39% |
| CAGR/Max DD | -0.23 |
Description: WKL Wolters Kluwer
Wolters Kluwer N.V. provides professional information, software solutions, and services in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, Africa, and internationally. The company operates through Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG segments. The Health segment offers clinical technology and solutions that drive effective decision-making and outcomes across the continuum of healthcare. It serves hospitals, healthcare organizations, clinicians, students, schools, libraries, payers, life sciences, digital health companies, and pharmacies. The Tax & Accounting segment offers solutions that help tax, accounting, and audit professionals to drive productivity, navigate change, and deliver better outcomes. It serves accounting firms, tax and auditing departments, businesses of all sizes, government agencies, libraries, and universities. The Financial & Corporate Compliance segment offers solutions for legal entity and banking product compliance. It serves corporations, small businesses, law firms, banks, non-bank lenders, credit unions, insurers, and securities firms. The Legal & Regulatory segment provides information, insights, and workflow solutions for changing regulatory obligations, managing risk, and increasing efficiency. It serves legal and compliance professionals in law firms, corporate legal departments, universities, and government organizations. The Corporate Performance & ESG segment offers enterprise software to drive financial and sustainability performance and manage risks, meet reporting requirements, improve safety and productivity, and reduce environmental impact. The company also develops a hosted platform for managing and controlling external legal costs. Wolters Kluwer N.V. was founded in 1836 and is headquartered in Alphen aan den Rijn, the Netherlands.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 2.16b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.29 > 0.02 and ΔFCF/TA 12.26 > 1.0 |
| NWC/Revenue: -8.94% < 20% (prev -15.51%; Δ 6.57% < -1%) |
| CFO/TA 0.33 > 3% & CFO 3.19b > Net Income 2.16b |
| Net Debt (4.29b) to EBITDA (3.84b): 1.12 < 3 |
| Current Ratio: 0.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (234.0m) vs 12m ago -5.65% < -2% |
| Gross Margin: 66.49% > 18% (prev 0.71%; Δ 6578 % > 0.5%) |
| Asset Turnover: 125.7% > 50% (prev 61.38%; Δ 64.31% > 0%) |
| Interest Coverage Ratio: 32.49 > 6 (EBITDA TTM 3.84b / Interest Expense TTM 89.0m) |
Altman Z'' 1.90
| A: -0.11 (Total Current Assets 2.61b - Total Current Liabilities 3.67b) / Total Assets 9.73b |
| B: 0.14 (Retained Earnings 1.36b / Total Assets 9.73b) |
| C: 0.31 (EBIT TTM 2.89b / Avg Total Assets 9.41b) |
| D: 0.09 (Book Value of Equity 800.0m / Total Liabilities 8.85b) |
| Altman-Z'' Score: 1.90 = BBB |
Beneish M -2.64
| DSRI: 0.52 (Receivables 1.60b/1.46b, Revenue 11.83b/5.58b) |
| GMI: 1.07 (GM 66.49% / 71.01%) |
| AQI: 1.05 (AQ_t 0.71 / AQ_t-1 0.67) |
| SGI: 2.12 (Revenue 11.83b / 5.58b) |
| TATA: -0.11 (NI 2.16b - CFO 3.19b) / TA 9.73b) |
| Beneish M-Score: -2.64 (Cap -4..+1) = A |
What is the price of WKL shares?
As of February 28, 2026, the stock is trading at EUR 66.10 with a total of 2,121,906 shares traded.
Over the past week, the price has changed by +6.07%, over one month by -20.86%, over three months by -27.92% and over the past year by -56.21%.
Over the past week, the price has changed by +6.07%, over one month by -20.86%, over three months by -27.92% and over the past year by -56.21%.
Is WKL a buy, sell or hold?
Wolters Kluwer has no consensus analysts rating.
What are the forecasts/targets for the WKL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 136.8 | 106.9% |
| Analysts Target Price | - | - |
WKL Fundamental Data Overview February 26, 2026
Market Cap USD = 16.60b (14.03b EUR * 1.1832 EUR.USD)
P/E Trailing = 13.0672
P/E Forward = 20.0401
P/S = 2.3085
P/B = 28.9978
P/EG = 2.1788
Revenue TTM = 11.83b EUR
EBIT TTM = 2.89b EUR
EBITDA TTM = 3.84b EUR
Long Term Debt = 4.45b EUR (from longTermDebt, last quarter)
Short Term Debt = 600.0m EUR (from shortTermDebt, last quarter)
Debt = 5.23b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.29b EUR (from netDebt column, last quarter)
Enterprise Value = 18.32b EUR (14.03b + Debt 5.23b - CCE 942.0m)
Interest Coverage Ratio = 32.49 (Ebit TTM 2.89b / Interest Expense TTM 89.0m)
EV/FCF = 6.42x (Enterprise Value 18.32b / FCF TTM 2.85b)
FCF Yield = 15.58% (FCF TTM 2.85b / Enterprise Value 18.32b)
FCF Margin = 24.13% (FCF TTM 2.85b / Revenue TTM 11.83b)
Net Margin = 18.26% (Net Income TTM 2.16b / Revenue TTM 11.83b)
Gross Margin = 66.49% ((Revenue TTM 11.83b - Cost of Revenue TTM 3.96b) / Revenue TTM)
Gross Margin QoQ = 65.20% (prev 64.33%)
Tobins Q-Ratio = 1.88 (Enterprise Value 18.32b / Total Assets 9.73b)
Interest Expense / Debt = 0.73% (Interest Expense 38.0m / Debt 5.23b)
Taxrate = 23.93% (174.0m / 727.0m)
NOPAT = 2.20b (EBIT 2.89b * (1 - 23.93%))
Current Ratio = 0.71 (Total Current Assets 2.61b / Total Current Liabilities 3.67b)
Debt / Equity = 5.90 (Debt 5.23b / totalStockholderEquity, last quarter 887.0m)
Debt / EBITDA = 1.12 (Net Debt 4.29b / EBITDA 3.84b)
Debt / FCF = 1.50 (Net Debt 4.29b / FCF TTM 2.85b)
Total Stockholder Equity = 1.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.96% (Net Income 2.16b / Total Assets 9.73b)
RoE = 151.1% (Net Income TTM 2.16b / Total Stockholder Equity 1.43b)
RoCE = 49.15% (EBIT 2.89b / Capital Employed (Equity 1.43b + L.T.Debt 4.45b))
RoIC = 40.92% (NOPAT 2.20b / Invested Capital 5.38b)
WACC = 5.65% (E(14.03b)/V(19.26b) * Re(7.55%) + D(5.23b)/V(19.26b) * Rd(0.73%) * (1-Tc(0.24)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.16%
[DCF] Terminal Value 87.20% ; FCFF base≈2.33b ; Y1≈2.56b ; Y5≈3.26b
[DCF] Fair Price = 408.0 (EV 96.23b - Net Debt 4.29b = Equity 91.94b / Shares 225.3m; r=5.90% [WACC]; 5y FCF grow 11.08% → 2.90% )
EPS Correlation: -10.55 | EPS CAGR: -60.51% | SUE: 0.0 | # QB: 0
Revenue Correlation: 68.58 | Revenue CAGR: 10.68% | SUE: -0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=5.72 | Chg7d=-0.031 | Chg30d=-0.036 | Revisions Net=-1 | Growth EPS=+8.6% | Growth Revenue=+3.0%
P/E Trailing = 13.0672
P/E Forward = 20.0401
P/S = 2.3085
P/B = 28.9978
P/EG = 2.1788
Revenue TTM = 11.83b EUR
EBIT TTM = 2.89b EUR
EBITDA TTM = 3.84b EUR
Long Term Debt = 4.45b EUR (from longTermDebt, last quarter)
Short Term Debt = 600.0m EUR (from shortTermDebt, last quarter)
Debt = 5.23b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.29b EUR (from netDebt column, last quarter)
Enterprise Value = 18.32b EUR (14.03b + Debt 5.23b - CCE 942.0m)
Interest Coverage Ratio = 32.49 (Ebit TTM 2.89b / Interest Expense TTM 89.0m)
EV/FCF = 6.42x (Enterprise Value 18.32b / FCF TTM 2.85b)
FCF Yield = 15.58% (FCF TTM 2.85b / Enterprise Value 18.32b)
FCF Margin = 24.13% (FCF TTM 2.85b / Revenue TTM 11.83b)
Net Margin = 18.26% (Net Income TTM 2.16b / Revenue TTM 11.83b)
Gross Margin = 66.49% ((Revenue TTM 11.83b - Cost of Revenue TTM 3.96b) / Revenue TTM)
Gross Margin QoQ = 65.20% (prev 64.33%)
Tobins Q-Ratio = 1.88 (Enterprise Value 18.32b / Total Assets 9.73b)
Interest Expense / Debt = 0.73% (Interest Expense 38.0m / Debt 5.23b)
Taxrate = 23.93% (174.0m / 727.0m)
NOPAT = 2.20b (EBIT 2.89b * (1 - 23.93%))
Current Ratio = 0.71 (Total Current Assets 2.61b / Total Current Liabilities 3.67b)
Debt / Equity = 5.90 (Debt 5.23b / totalStockholderEquity, last quarter 887.0m)
Debt / EBITDA = 1.12 (Net Debt 4.29b / EBITDA 3.84b)
Debt / FCF = 1.50 (Net Debt 4.29b / FCF TTM 2.85b)
Total Stockholder Equity = 1.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.96% (Net Income 2.16b / Total Assets 9.73b)
RoE = 151.1% (Net Income TTM 2.16b / Total Stockholder Equity 1.43b)
RoCE = 49.15% (EBIT 2.89b / Capital Employed (Equity 1.43b + L.T.Debt 4.45b))
RoIC = 40.92% (NOPAT 2.20b / Invested Capital 5.38b)
WACC = 5.65% (E(14.03b)/V(19.26b) * Re(7.55%) + D(5.23b)/V(19.26b) * Rd(0.73%) * (1-Tc(0.24)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.16%
[DCF] Terminal Value 87.20% ; FCFF base≈2.33b ; Y1≈2.56b ; Y5≈3.26b
[DCF] Fair Price = 408.0 (EV 96.23b - Net Debt 4.29b = Equity 91.94b / Shares 225.3m; r=5.90% [WACC]; 5y FCF grow 11.08% → 2.90% )
EPS Correlation: -10.55 | EPS CAGR: -60.51% | SUE: 0.0 | # QB: 0
Revenue Correlation: 68.58 | Revenue CAGR: 10.68% | SUE: -0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=5.72 | Chg7d=-0.031 | Chg30d=-0.036 | Revisions Net=-1 | Growth EPS=+8.6% | Growth Revenue=+3.0%